Cayuga Biotech introduced groundbreaking preclinical findings today on its innovative polyphosphate (polyP)-based therapy aimed at combating life-threatening hemorrhage. The study revealed that the polyP-SNP (silica nanoparticle) complex accelerates thrombin production 12 times faster than conventional methods under both standard and…
PQE Group, a prominent consultancy in the Life Science sector, has announced the launch of its new Regulated Artificial Intelligence & Data Analytics division. This development follows the integration of AI-based tools within the industrial sector, marking a significant milestone…
Takeda has announced that the European Commission (EC) has approved FRUZAQLA (fruquintinib) as a monotherapy for adult patients with metastatic colorectal cancer (mCRC) who have previously been treated with standard therapies. These therapies include fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapies, anti-VEGF…
Sanofi is set to present new data from its hemophilia portfolio at the 32nd Congress of the International Society on Thrombosis and Haemostasis (ISTH), occurring from June 22-26, 2024, in Bangkok, Thailand. Key presentations on ALTUVIIIO [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN…
Eli Lilly and Company (NYSE: LLY) has released detailed results from the SURMOUNT-OSA phase 3 clinical trials, which evaluated tirzepatide injections (10 mg or 15 mg) for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity, with and without…
Sanofi and Biovac, based in Cape Town, South Africa, have announced a significant partnership aimed at local manufacturing of inactivated polio vaccines (IPV) across Africa. This collaboration marks a milestone as Biovac becomes the first African producer of IPV on…
Takeda Releases Phase 3 Topline Results for Soticlestat (TAK-935) in Dravet Syndrome and Lennox-Gastaut Syndrome OSAKA, Japan & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda (TSE:4502/NYSE The SKYLINE trial (TAK-935-3001) was a multicenter, randomized, double-blind Phase 3 study examining soticlestat (TAK-935) alongside standard care…
UMC Utrecht has enrolled its first patient for a new study to identify biomarkers of Amyotrophic Lateral Sclerosis (ALS). The observational investigator-initiated study is led by Professor Dr. Leonard van den Berg and supported by VectorY Therapeutics. VectorY Therapeutics is…
Celltrion today presented positive Phase III data for CT-P47, a biosimilar referencing RoActemra® in patients with moderate-to-severe rheumatoid arthritis (RA), at the Annual European Congress of Rheumatology (EULAR) 2024. The trial demonstrated that CT-P47 has equivalent efficacy and comparable safety…
Kirin Holdings Company, Limited (Kirin Holdings) (TOKYO: 2503) has announced its intention to acquire additional shares of common stock of FANCL Corporation (FANCL) (TOKYO: 4921) through a tender offer and share warrants, with the goal of making FANCL a wholly-owned…
The World Health Organization has released a new guideline outlining effective strategies to foster food environments that support healthy dietary choices. Emphasizing fiscal policies as a pivotal tool, the guideline recommends measures to discourage consumption of foods linked to unhealthy…
Zimbabwe has reached maturity level 3 (ML 3) in the WHO’s classification of regulatory authorities for medicines, marking a significant achievement in healthcare infrastructure. This classification, assessed using WHO’s Global Benchmarking Tool with over 260 indicators, signifies the establishment of…
